{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:37:12Z","timestamp":1790897832786,"version":"4.1.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s10072-022-06581-z","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T13:11:05Z","timestamp":1673269865000},"page":"1505-1513","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Neurological sequelae of vaccines"],"prefix":"10.1007","volume":"44","author":[{"given":"Lindsay S.","family":"McAlpine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9809-7888","authenticated-orcid":false,"given":"Adeel S.","family":"Zubair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,9]]},"reference":[{"issue":"9B","key":"6581_CR1","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1590\/0004-282X20130163","volume":"71","author":"GD Rabello","year":"2013","unstructured":"Rabello GD (2013) Postvaccinal neurological complications. Arq Neuropsiquiatr 71(9B):747\u2013751","journal-title":"Arq Neuropsiquiatr"},{"issue":"8","key":"6581_CR2","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1093\/occmed\/kqm110","volume":"57","author":"D Baxter","year":"2007","unstructured":"Baxter D (2007) Active and passive immunity, vaccine types, excipients and licensing. Occup Med (Lond) 57(8):552\u2013556","journal-title":"Occup Med (Lond)"},{"issue":"10","key":"6581_CR3","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nrg2432","volume":"9","author":"MA Kutzler","year":"2008","unstructured":"Kutzler MA, Weiner DB (2008) DNA vaccines: ready for prime time? Nat Rev Genet 9(10):776\u2013788","journal-title":"Nat Rev Genet"},{"issue":"4","key":"6581_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi N et al (2018) mRNA vaccines \u2014 a new era in vaccinology. Nat Rev Drug Discovery 17(4):261\u2013279","journal-title":"Nat Rev Drug Discovery"},{"key":"6581_CR5","volume-title":"\u00a9 2020","author":"AC Anilkumar","year":"2020","unstructured":"Anilkumar AC, Foris LA, Tadi P, Acute disseminated encephalomyelitis, in StatPearls. (2020) \u00a9 2020. StatPearls Publishing LLC., Treasure Island FL"},{"key":"6581_CR6","volume-title":"\u00a9 2020","author":"CG Simone","year":"2020","unstructured":"Simone CG, Emmady PD, Transverse myelitis, in StatPearls. (2020) \u00a9 2020. StatPearls Publishing LLC., Treasure Island FL"},{"issue":"3","key":"6581_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/00019052-200206000-00018","volume":"15","author":"S Piyasirisilp","year":"2002","unstructured":"Piyasirisilp S, Hemachudha T (2002) Neurological adverse events associated with vaccination. Curr Opin Neurol 15(3):333\u2013338","journal-title":"Curr Opin Neurol"},{"issue":"6","key":"6581_CR8","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.jinf.2022.04.026","volume":"84","author":"H Wang","year":"2022","unstructured":"Wang H et al (2022) Global magnitude of encephalitis burden and its evolving pattern over the past 30 years. J Infect 84(6):777\u2013787","journal-title":"J Infect"},{"issue":"8","key":"6581_CR9","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1212\/WNL.31.8.966","volume":"31","author":"M Berman","year":"1981","unstructured":"Berman M et al (1981) Acute transverse myelitis: incidence and etiologic considerations. Neurology 31(8):966\u2013966","journal-title":"Neurology"},{"issue":"1","key":"6581_CR10","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12974-021-02319-4","volume":"18","author":"NL Bragazzi","year":"2021","unstructured":"Bragazzi NL et al (2021) Global, regional, and national burden of Guillain-Barr\u00e9 syndrome and its underlying causes from 1990 to 2019. J Neuroinflammation 18(1):264","journal-title":"J Neuroinflammation"},{"key":"6581_CR11","unstructured":"Ortiz Torres M, GA, Mesfin FB (2022) Brachial plexitis. StatPearls Publishing."},{"key":"6581_CR12","doi-asserted-by":"crossref","unstructured":"Seizures SOF, Febrile seizures: guideline for the neurodiagnostic evaluation of the child with a simple febrile seizure. Pediatrics 127(2) 389\u2013394.","DOI":"10.1542\/peds.2010-3318"},{"key":"6581_CR13","volume-title":"\u00a9 2020","author":"C Bae","year":"2020","unstructured":"Bae C, Bourget D, Tetanus, in StatPearls. (2020) \u00a9 2020. StatPearls Publishing LLC., Treasure Island FL"},{"issue":"7704","key":"6581_CR14","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/S0140-6736(71)91496-6","volume":"1","author":"LS Illis","year":"1971","unstructured":"Illis LS, Taylor FM (1971) Neurological and electroencephalographic sequelae of tetanus. Lancet 1(7704):826\u2013830","journal-title":"Lancet"},{"key":"6581_CR15","unstructured":"Adverse events associated with childhood vaccines: evidence bearing on causality, ed. K.R. Stratton, C.J. Howe, and R.B. Johnston, Jr. 1994, Washington DC: 1994 by the National Academy of Sciences."},{"key":"6581_CR16","volume-title":"\u00a9 2020","author":"A Chaudhary","year":"2020","unstructured":"Chaudhary A, Pandey S, Corynebacterium diphtheriae, in StatPearls. (2020) \u00a9 2020. StatPearls Publishing LLC., Treasure Island FL"},{"issue":"26","key":"6581_CR17","doi-asserted-by":"publisher","first-page":"17723","DOI":"10.1016\/S0021-9258(17)32500-0","volume":"269","author":"IH Madshus","year":"1994","unstructured":"Madshus IH (1994) The N-terminal alpha-helix of fragment B of diphtheria toxin promotes translocation of fragment A into the cytoplasm of eukaryotic cells. J Biol Chem 269(26):17723\u201317729","journal-title":"J Biol Chem"},{"issue":"13","key":"6581_CR18","doi-asserted-by":"publisher","first-page":"8957","DOI":"10.1016\/S0021-9258(19)50373-8","volume":"267","author":"H Stenmark","year":"1992","unstructured":"Stenmark H et al (1992) Interactions of diphtheria toxin B-fragment with cells Role of amino- and carboxyl-terminal regions. J Biol Chem 267(13):8957\u201362","journal-title":"J Biol Chem"},{"issue":"2","key":"6581_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s40471-015-0041-9","volume":"2","author":"JD Cherry","year":"2015","unstructured":"Cherry JD (2015) The history of pertussis (Whooping Cough); 1906\u20132015: facts, myths, and misconceptions. Current Epidemiology Reports 2(2):120\u2013130","journal-title":"Current Epidemiology Reports"},{"issue":"8327","key":"6581_CR20","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S0140-6736(83)92037-8","volume":"1","author":"TM Pollock","year":"1983","unstructured":"Pollock TM, Morris J (1983) A 7-year survey of disorders attributed to vaccination in North West Thames region. Lancet 1(8327):753\u2013757","journal-title":"Lancet"},{"issue":"5","key":"6581_CR21","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1542\/peds.68.5.650","volume":"68","author":"CL Cody","year":"1981","unstructured":"Cody CL et al (1981) Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 68(5):650\u2013660","journal-title":"Pediatrics"},{"issue":"2","key":"6581_CR22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/00006454-198503000-00011","volume":"4","author":"RM Barkin","year":"1985","unstructured":"Barkin RM et al (1985) Primary immunization with diphtheria-tetanus toxoids vaccine and diphtheria-tetanus toxoids-pertussis vaccine adsorbed: comparison of schedules. Pediatr Infect Dis 4(2):168\u2013171","journal-title":"Pediatr Infect Dis"},{"issue":"11","key":"6581_CR23","doi-asserted-by":"publisher","first-page":"511","DOI":"10.5694\/j.1326-5377.1982.tb132550.x","volume":"2","author":"BJ Feery","year":"1982","unstructured":"Feery BJ (1982) Incidence and type of reactions to triple antigen (DTP) and DT (CDT) vaccines. Med J Aust 2(11):511\u2013515","journal-title":"Med J Aust"},{"issue":"11","key":"6581_CR24","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1136\/adc.58.11.921","volume":"58","author":"PA Waight","year":"1983","unstructured":"Waight PA et al (1983) Pyrexia after diphtheria\/tetanus\/pertussis and diphtheria\/tetanus vaccines. Arch Dis Child 58(11):921\u2013923","journal-title":"Arch Dis Child"},{"key":"6581_CR25","first-page":"25","volume":"43","author":"U Quast","year":"1979","unstructured":"Quast U, Hennessen W, Widmark RM (1979) Mono- and polyneuritis after tetanus vaccination (1970\u20131977). Dev Biol Stand 43:25\u201332","journal-title":"Dev Biol Stand"},{"issue":"8801","key":"6581_CR26","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/0140-6736(92)90703-6","volume":"339","author":"SJ Read","year":"1992","unstructured":"Read SJ, Schapel GJ, Pender MP (1992) Acute transverse myelitis after tetanus toxoid vaccination. Lancet 339(8801):1111\u20131112","journal-title":"Lancet"},{"issue":"8786","key":"6581_CR27","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/0140-6736(92)90241-T","volume":"339","author":"H Topaloglu","year":"1992","unstructured":"Topaloglu H et al (1992) Optic neuritis and myelitis after booster tetanus toxoid vaccination. Lancet 339(8786):178\u2013179","journal-title":"Lancet"},{"issue":"6074","key":"6581_CR28","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1136\/bmj.1.6074.1450","volume":"1","author":"E Whittle","year":"1977","unstructured":"Whittle E, Robertson NR (1977) Transverse myelitis after diphtheria, tetanus, and polio immunisation. Br Med J 1(6074):1450","journal-title":"Br Med J"},{"issue":"1","key":"6581_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1001\/archneur.1983.04050010076025","volume":"40","author":"PL Holliday","year":"1983","unstructured":"Holliday PL, Bauer RB (1983) Polyradiculoneuritis secondary to immunization with tetanus and diphtheria toxoids. Arch Neurol 40(1):56\u201357","journal-title":"Arch Neurol"},{"key":"6581_CR30","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1097\/00007611-198708000-00028","volume":"8","author":"N Newton Jr","year":"1987","unstructured":"Newton N Jr, Janati A (1987) Guillain-Barr\u00e9 syndrome after vaccination with purified tetanus toxoid. South Med J 8:1053\u20134","journal-title":"South Med J"},{"key":"6581_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0022-510X(78)90232-0","volume":"1\u20132","author":"JD Pollard","year":"1978","unstructured":"Pollard JD, Selby G (1978) Relapsing neuropathy due to tetanus toxoid Report of a case. J Neurol Sci 1\u20132:113\u201325","journal-title":"J Neurol Sci"},{"issue":"36","key":"6581_CR32","first-page":"1965","volume":"53","author":"M Bensasson","year":"1977","unstructured":"Bensasson M, Lanoe R, Assan R (1977) A case of algodystrophic syndrome of the upper limb following tetanus vaccination. Sem Hop 53(36):1965\u20131966","journal-title":"Sem Hop"},{"issue":"34","key":"6581_CR33","first-page":"1692","volume":"111","author":"W Eicher","year":"1969","unstructured":"Eicher W, Neund\u00f6rfer B (1969) Paralysis of the recurrent laryngeal nerve following a booster injection of tetanus toxoid (associated with local allergic reaction). Munch Med Wochenschr 111(34):1692\u20131695","journal-title":"Munch Med Wochenschr"},{"issue":"3","key":"6581_CR34","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1136\/jnnp.47.3.320","volume":"47","author":"JC Kiwit","year":"1984","unstructured":"Kiwit JC (1984) Neuralgic amyotrophy after administration of tetanus toxoid. J Neurol Neurosurg Psychiatry 47(3):320","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"6581_CR35","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/0020-1383(76)90012-7","volume":"8","author":"CM Ling","year":"1976","unstructured":"Ling CM, Loong SC (1976) Injection injury of the radial nerve. Injury 8(1):60\u201362","journal-title":"Injury"},{"issue":"12","key":"6581_CR36","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1001\/jamapediatrics.2016.1787","volume":"170","author":"JC Bester","year":"2016","unstructured":"Bester JC (2016) Measles and measles vaccination: a review. JAMA Pediatr 170(12):1209\u20131215","journal-title":"JAMA Pediatr"},{"key":"6581_CR37","doi-asserted-by":"crossref","unstructured":"Su, S.B., H.L. Chang, and A.K. Chen, Current status of mumps virus infection: epidemiology, pathogenesis, and vaccine. Int J Environ Res Public Health 2020. 17(5).","DOI":"10.3390\/ijerph17051686"},{"key":"6581_CR38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0022-3476(46)80101-X","volume":"29","author":"JF Enders","year":"1946","unstructured":"Enders JF (1946) Mumps; techniques of laboratory diagnosis, tests for susceptibility, and experiments on specific prophylaxis. J Pediatr 29:129\u2013142","journal-title":"J Pediatr"},{"issue":"2","key":"6581_CR39","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1001\/jama.1967.03120020123031","volume":"199","author":"RC Trump","year":"1967","unstructured":"Trump RC, White TR (1967) Cerebellar ataxia presumed due to live, attenuated measles virus vaccine. JAMA 199(2):129\u2013130","journal-title":"JAMA"},{"issue":"5","key":"6581_CR40","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1542\/peds.41.5.997","volume":"41","author":"PR Nader","year":"1968","unstructured":"Nader PR, Warren RJ (1968) Reported neurologic disorders following live measles vaccine. Pediatrics 41(5):997\u20131001","journal-title":"Pediatrics"},{"issue":"13","key":"6581_CR41","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1001\/jama.1973.03220130011003","volume":"223","author":"PJ Landrigan","year":"1973","unstructured":"Landrigan PJ, Witte JJ (1973) Neurologic disorders following live measles-virus vaccination. JAMA 223(13):1459\u20131462","journal-title":"JAMA"},{"issue":"11","key":"6581_CR42","first-page":"1116","volume":"67","author":"AJ Beale","year":"1974","unstructured":"Beale AJ (1974) Measles vaccines. Proc R Soc Med 67(11):1116\u20131119","journal-title":"Proc R Soc Med"},{"issue":"52","key":"6581_CR43","first-page":"2489","volume":"31","author":"HJ Dietzsch","year":"1976","unstructured":"Dietzsch HJ, Kiehl W (1976) Central nervous complications following measles vaccination. Dtsch Gesundheitsw 31(52):2489\u20132491","journal-title":"Dtsch Gesundheitsw"},{"issue":"12","key":"6581_CR44","first-page":"948","volume":"84","author":"J Taranger","year":"1987","unstructured":"Taranger J, Wiholm BE (1987) The low number of reported adverse effects after vaccination against measles, mumps, rubella. Lakartidningen 84(12):948\u2013950","journal-title":"Lakartidningen"},{"key":"6581_CR45","unstructured":"Alderslade R, B.M., Rawson NSB, Ross EM, Miller DL (1981) The National Childhood Encephalopathy Study: a report on 1000 cases of serious neurological disorders in infants and young children from the NCES research team. Department of Health and Social Security. Whooping Cough: Reports from the Committee on the Safety of Medicines and the Joint Committee on Vaccination and Immunisation."},{"issue":"8822","key":"6581_CR46","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/0140-6736(92)92322-7","volume":"340","author":"A Colville","year":"1992","unstructured":"Colville A, Pugh S (1992) Mumps meningitis and measles, mumps, and rubella vaccine. Lancet 340(8822):786","journal-title":"Lancet"},{"issue":"5","key":"6581_CR47","first-page":"302","volume":"8","author":"M Cizman","year":"1989","unstructured":"Cizman M et al (1989) Aseptic meningitis after vaccination against measles and mumps. Pediatr Infect Dis J 8(5):302\u2013308","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"6581_CR48","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/00006454-199103000-00008","volume":"10","author":"A Sugiura","year":"1991","unstructured":"Sugiura A, Yamada A (1991) Aseptic meningitis as a complication of mumps vaccination. Pediatr Infect Dis J 10(3):209\u2013213","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"6581_CR49","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/00006454-199103000-00007","volume":"10","author":"T Fujinaga","year":"1991","unstructured":"Fujinaga T et al (1991) A prefecture-wide survey of mumps meningitis associated with measles, mumps and rubella vaccine. Pediatr Infect Dis J 10(3):204\u2013209","journal-title":"Pediatr Infect Dis J"},{"key":"6581_CR50","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0264-410X(90)90090-9","volume":"4","author":"R Fescharek","year":"1990","unstructured":"Fescharek R et al (1990) Measles-mumps vaccination in the FRG: an empirical analysis after 14 years of use I Efficacy and analysis of vaccine failures. Vaccine 4:333\u20136","journal-title":"Vaccine"},{"issue":"4","key":"6581_CR51","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0387-7604(85)80140-6","volume":"7","author":"T Abe","year":"1985","unstructured":"Abe T et al (1985) Acute and delayed neurologic reaction to inoculation with attenuated live measles virus. Brain Dev 7(4):421\u2013423","journal-title":"Brain Dev"},{"issue":"11","key":"6581_CR52","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJM196909112811103","volume":"281","author":"FE Payne","year":"1969","unstructured":"Payne FE, Baublis JV, Itabashi HH (1969) Isolation of measles virus from cell cultures of brain from a patient with subacute sclerosing panencephalitis. N Engl J Med 281(11):585\u2013589","journal-title":"N Engl J Med"},{"key":"6581_CR53","first-page":"275","volume":"2","author":"JC Parker Jr","year":"1970","unstructured":"Parker JC Jr et al (1970) Uncommon morphologic features in subacute sclerosing panencephalitis (SSPE). Report of two cases with virus recovery from one autopsy brain specimen. Am J Pathol 2:275\u201392","journal-title":"Am J Pathol"},{"issue":"2","key":"6581_CR54","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1056\/NEJM197107082850203","volume":"285","author":"KL Gerson","year":"1971","unstructured":"Gerson KL, Haslam RH (1971) Subtle immunologic abnormalities in four boys with subacute sclerosing panencephalitis. N Engl J Med 285(2):78\u201382","journal-title":"N Engl J Med"},{"issue":"9","key":"6581_CR55","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1001\/jama.1973.03220230059028","volume":"224","author":"CT Cho","year":"1973","unstructured":"Cho CT, Lansky LJ, D\u2019Souza BJ (1973) Panencephalitis following measles vaccination. JAMA 224(9):1299","journal-title":"JAMA"},{"issue":"3","key":"6581_CR56","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/0002-9343(76)90762-2","volume":"60","author":"C Grose","year":"1976","unstructured":"Grose C, Spigland I (1976) Guillain-Barr\u00e9 syndrome following administration of live measles vaccine. Am J Med 60(3):441\u2013443","journal-title":"Am J Med"},{"key":"6581_CR57","doi-asserted-by":"crossref","unstructured":"Tarantola, A., Four thousand years of concepts relating to rabies in animals and humans its prevention and its cure. Trop Med Infect Dis 2017. 2(2).","DOI":"10.3390\/tropicalmed2020005"},{"key":"6581_CR58","doi-asserted-by":"crossref","unstructured":"Radhakrishnan, S., et al., Rabies as a public health concern in india-a historical perspective. Trop Med Infect Dis 2020. 5(4).","DOI":"10.3390\/tropicalmed5040162"},{"issue":"3","key":"6581_CR59","first-page":"321","volume":"46","author":"JR Held","year":"1972","unstructured":"Held JR, Adaros HL (1972) Neurological disease in man following administration of suckling mouse brain antirabies vaccine. Bull World Health Organ 46(3):321\u2013327","journal-title":"Bull World Health Organ"},{"issue":"2","key":"6581_CR60","first-page":"150","volume":"40","author":"MS Tullu","year":"2003","unstructured":"Tullu MS et al (2003) Neurological complications of rabies vaccines. Indian Pediatr 40(2):150\u2013154","journal-title":"Indian Pediatr"},{"issue":"7","key":"6581_CR61","first-page":"502","volume":"19","author":"R Ramezankhani","year":"2016","unstructured":"Ramezankhani R et al (2016) A comparative study on the adverse reactions of purified chick embryo cell vaccine (PCECV) and purified vero cell rabies vaccine (PVRV). Arch Iran Med 19(7):502\u2013507","journal-title":"Arch Iran Med"},{"issue":"2","key":"6581_CR62","doi-asserted-by":"publisher","first-page":"428","DOI":"10.4161\/21645515.2014.995059","volume":"11","author":"BJ Mahendra","year":"2015","unstructured":"Mahendra BJ et al (2015) Comparative study on the immunogenicity and safety of a purified chick embryo cell rabies vaccine (PCECV) administered according to two different simulated post exposure intramuscular regimens (Zagreb versus Essen). Hum Vaccin Immunother 11(2):428\u2013434","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"6581_CR63","doi-asserted-by":"publisher","first-page":"435","DOI":"10.4161\/21645515.2014.994460","volume":"11","author":"R Li","year":"2015","unstructured":"Li R et al (2015) Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: a randomized open-label study. Hum Vaccin Immunother 11(2):435\u2013442","journal-title":"Hum Vaccin Immunother"},{"issue":"19","key":"6581_CR64","first-page":"e2610","volume":"95","author":"Y Wang","year":"2020","unstructured":"Wang Y et al (2020) Global prevalence and burden of HIV-associated neurocognitive disorder. A meta-analysis 95(19):e2610\u2013e2621","journal-title":"A meta-analysis"},{"issue":"2822","key":"6581_CR65","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1126\/science.109.2822.85","volume":"109","author":"JF Enders","year":"1949","unstructured":"Enders JF, Weller TH, Robbins FC (1949) Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues. Science 109(2822):85\u201387","journal-title":"Science"},{"issue":"5","key":"6581_CR66","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1542\/peds.12.5.471","volume":"12","author":"JE Salk","year":"1953","unstructured":"Salk JE (1953) Recent studies on immunization against poliomyelitis. Pediatrics 12(5):471\u2013482","journal-title":"Pediatrics"},{"key":"6581_CR67","unstructured":"Douglas, S.D. and R. Anolik, Postvaccination paralysis in a 20-month-old child. Hosp Pract (Off Ed), 1981. 16(9): p. 40A, 40F."},{"issue":"8660","key":"6581_CR68","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/S0140-6736(89)90609-0","volume":"2","author":"M Uhari","year":"1989","unstructured":"Uhari M, Rantala H, Niemel\u00e4 M (1989) Cluster of childhood Guillain-Barr\u00e9 cases after an oral poliovaccine campaign. Lancet 2(8660):440\u2013441","journal-title":"Lancet"},{"issue":"8","key":"6581_CR69","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1212\/WNL.39.8.1034","volume":"39","author":"E Kinnunen","year":"1989","unstructured":"Kinnunen E et al (1989) Incidence of Guillain-Barr\u00e9 syndrome during a nationwide oral poliovirus vaccine campaign. Neurology 39(8):1034\u20131036","journal-title":"Neurology"},{"issue":"1","key":"6581_CR70","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/BF01646107","volume":"15","author":"MR Hilleman","year":"1987","unstructured":"Hilleman MR (1987) Yeast recombinant hepatitis B vaccine. Infection 15(1):3\u20137","journal-title":"Infection"},{"issue":"2","key":"6581_CR71","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/oxfordjournals.aje.a114808","volume":"127","author":"FE Shaw Jr","year":"1988","unstructured":"Shaw FE Jr et al (1988) Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination Experience of the first three years. Am J Epidemiol 127(2):337\u201352","journal-title":"Am J Epidemiol"},{"issue":"3","key":"6581_CR72","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/0002-9343(92)90073-K","volume":"92","author":"BJ McMahon","year":"1992","unstructured":"McMahon BJ et al (1992) Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons. Am J Med 92(3):254\u2013256","journal-title":"Am J Med"},{"issue":"8776","key":"6581_CR73","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/0140-6736(91)92034-Y","volume":"338","author":"L Herroelen","year":"1991","unstructured":"Herroelen L, de Keyser J, Ebinger G (1991) Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine. Lancet 338(8776):1174\u20131175","journal-title":"Lancet"},{"issue":"4","key":"6581_CR74","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.jpeds.2014.12.014","volume":"166","author":"PL Moro","year":"2015","unstructured":"Moro PL et al (2015) Adverse events following Haemophilus influenzae type b vaccines in the Vaccine Adverse Event Reporting System, 1990\u20132013. J Pediatr 166(4):992\u2013997","journal-title":"J Pediatr"},{"issue":"3","key":"6581_CR75","first-page":"235","volume":"66","author":"J Nishi","year":"2013","unstructured":"Nishi J et al (2013) Prospective safety monitoring of <i>Haemophilus influenzae<\/i> type b and heptavalent pneumococcal conjugate vaccines in Kagoshima. Japan Japanese Journal of Infectious Diseases 66(3):235\u2013237","journal-title":"Japan Japanese Journal of Infectious Diseases"},{"issue":"3","key":"6581_CR76","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1442-200X.2012.03568.x","volume":"54","author":"SJ Lee","year":"2012","unstructured":"Lee SJ et al (2012) Neurologic adverse events following influenza A (H1N1) vaccinations in children. Pediatr Int 54(3):325\u2013330","journal-title":"Pediatr Int"},{"issue":"46","key":"6581_CR77","doi-asserted-by":"publisher","first-page":"8302","DOI":"10.1016\/j.vaccine.2011.08.093","volume":"29","author":"SE Williams","year":"2011","unstructured":"Williams SE et al (2011) Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination. Vaccine 29(46):8302\u20138308","journal-title":"Vaccine"},{"issue":"3","key":"6581_CR78","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/irv.12241","volume":"8","author":"G C\u00e1rdenas","year":"2014","unstructured":"C\u00e1rdenas G et al (2014) Neurological events related to influenza A (H1N1) pdm09. Influenza Other Respir Viruses 8(3):339\u2013346","journal-title":"Influenza Other Respir Viruses"},{"issue":"14","key":"6581_CR79","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1212\/WNL.0b013e31828ab26f","volume":"80","author":"A Szak\u00e1cs","year":"2013","unstructured":"Szak\u00e1cs A, Darin N, Hallb\u00f6\u00f6k T (2013) Increased childhood incidence of narcolepsy in western Sweden after H1N1 influenza vaccination. Neurology 80(14):1315","journal-title":"Neurology"},{"key":"6581_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2014.01.033","volume":"50","author":"SS Ahmed","year":"2014","unstructured":"Ahmed SS et al (2014) Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants. J Autoimmun 50:1\u201311","journal-title":"J Autoimmun"},{"issue":"3","key":"6581_CR81","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/1744666X.2020.1719832","volume":"16","author":"BR Kornum","year":"2020","unstructured":"Kornum BR, Jennum P (2020) The case for narcolepsy as an autoimmune disease. Expert Rev Clin Immunol 16(3):231\u2013233","journal-title":"Expert Rev Clin Immunol"},{"issue":"12","key":"6581_CR82","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1038\/nm.2972","volume":"18","author":"RL Graham","year":"2012","unstructured":"Graham RL et al (2012) A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease. Nat Med 18(12):1820\u20131826","journal-title":"Nat Med"},{"issue":"7","key":"6581_CR83","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1128\/JVI.03566-14","volume":"89","author":"JA Regla-Nava","year":"2015","unstructured":"Regla-Nava JA et al (2015) Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates. J Virol 89(7):3870\u20133887","journal-title":"J Virol"},{"issue":"4","key":"6581_CR84","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1128\/JVI.01467-06","volume":"81","author":"ML DeDiego","year":"2007","unstructured":"DeDiego ML et al (2007) A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo. J Virol 81(4):1701\u20131713","journal-title":"J Virol"},{"issue":"1","key":"6581_CR85","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.virol.2010.01.004","volume":"399","author":"J Netland","year":"2010","unstructured":"Netland J et al (2010) Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease. Virology 399(1):120\u2013128","journal-title":"Virology"},{"issue":"15","key":"6581_CR86","doi-asserted-by":"publisher","first-page":"7721","DOI":"10.1128\/JVI.00304-08","volume":"82","author":"EW Lamirande","year":"2008","unstructured":"Lamirande EW et al (2008) A live attenuated severe acute respiratory syndrome coronavirus is immunogenic and efficacious in golden Syrian hamsters. J Virol 82(15):7721\u20137724","journal-title":"J Virol"},{"issue":"6982","key":"6581_CR87","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nature02463","volume":"428","author":"ZY Yang","year":"2004","unstructured":"Yang ZY et al (2004) A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 428(6982):561\u2013564","journal-title":"Nature"},{"issue":"7","key":"6581_CR88","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1177\/135965350701200702","volume":"12","author":"JT Lin","year":"2007","unstructured":"Lin JT et al (2007) Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine. Antivir Ther 12(7):1107\u20131113","journal-title":"Antivir Ther"},{"issue":"50","key":"6581_CR89","doi-asserted-by":"publisher","first-page":"6338","DOI":"10.1016\/j.vaccine.2008.09.026","volume":"26","author":"JE Martin","year":"2008","unstructured":"Martin JE et al (2008) A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial. Vaccine 26(50):6338\u20136343","journal-title":"Vaccine"},{"issue":"4","key":"6581_CR90","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s12291-021-00968-z","volume":"36","author":"RJ Kaur","year":"2021","unstructured":"Kaur RJ et al (2021) Adverse events reported from COVID-19 vaccine trials: a systematic review. Indian J Clinical Biochemistry\u202f: IJCB 36(4):427\u2013439","journal-title":"Indian J Clinical Biochemistry : IJCB"},{"issue":"14","key":"6581_CR91","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1001\/jama.2021.15072","volume":"326","author":"NP Klein","year":"2021","unstructured":"Klein NP et al (2021) Surveillance for adverse events after COVID-19 mRNA vaccination. JAMA 326(14):1390\u20131399","journal-title":"JAMA"},{"key":"6581_CR92","unstructured":"Voysey M et al. (2020) Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet (London, England) p. S0140\u20136736(20)32661\u20131."},{"issue":"1","key":"6581_CR93","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/s12883-021-02427-x","volume":"21","author":"WY Tan","year":"2021","unstructured":"Tan WY et al (2021) Longitudinal extensive transverse myelitis following ChAdOx1 nCOV-19 vaccine: a case report. BMC Neurol 21(1):395","journal-title":"BMC Neurol"},{"key":"6581_CR94","doi-asserted-by":"publisher","first-page":"100019","DOI":"10.1016\/j.nerep.2021.100019","volume":"1","author":"P McLean","year":"2021","unstructured":"McLean P, Trefts L (2021) Transverse myelitis 48 hours after the administration of an mRNA COVID 19 vaccine. Neuroimmunology Reports 1:100019","journal-title":"Neuroimmunology Reports"},{"key":"6581_CR95","doi-asserted-by":"crossref","unstructured":"Khan, E., et al., Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature. Journal of neurology, 2021: p. 1\u201312.","DOI":"10.1007\/s00415-021-10785-2"},{"issue":"3","key":"6581_CR96","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00415-021-10785-2","volume":"269","author":"E Khan","year":"2022","unstructured":"Khan E et al (2022) Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature. J Neurol 269(3):1121\u20131132","journal-title":"J Neurol"},{"key":"6581_CR97","doi-asserted-by":"publisher","first-page":"e3286","DOI":"10.6061\/clinics\/2021\/e3286","volume":"76","author":"J Finsterer","year":"2021","unstructured":"Finsterer J, Scorza FA, Scorza CA (2021) Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients. Clinics (Sao Paulo) 76:e3286","journal-title":"Clinics (Sao Paulo)"},{"key":"6581_CR98","doi-asserted-by":"publisher","first-page":"102540","DOI":"10.1016\/j.amsu.2021.102540","volume":"67","author":"A Razok","year":"2021","unstructured":"Razok A et al (2021) Post-COVID-19 vaccine Guillain-Barr\u00e9 syndrome; first reported case from Qatar. Annals of Med Surg 67:102540","journal-title":"Annals of Med Surg"},{"issue":"7","key":"6581_CR99","doi-asserted-by":"publisher","first-page":"e244125","DOI":"10.1136\/bcr-2021-244125","volume":"14","author":"N McKean","year":"2021","unstructured":"McKean N, Chircop C (2021) Guillain-Barr\u00e9 syndrome after COVID-19 vaccination. BMJ Case Reports 14(7):e244125","journal-title":"BMJ Case Reports"},{"issue":"2","key":"6581_CR100","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/ana.26144","volume":"90","author":"CM Allen","year":"2021","unstructured":"Allen CM et al (2021) Guillain-Barr\u00e9 syndrome variant occurring after SARS-CoV-2 vaccination. Ann Neurol 90(2):315\u2013318","journal-title":"Ann Neurol"},{"issue":"12","key":"6581_CR101","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1038\/s41591-021-01556-7","volume":"27","author":"M Patone","year":"2021","unstructured":"Patone M et al (2021) Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat Med 27(12):2144\u20132153","journal-title":"Nat Med"},{"issue":"4","key":"6581_CR102","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S1473-3099(21)00076-1","volume":"21","author":"A Ozonoff","year":"2021","unstructured":"Ozonoff A, Nanishi E, Levy O (2021) Bell\u2019s palsy and SARS-CoV-2 vaccines. Lancet Infect Dis 21(4):450\u2013452","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"6581_CR103","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S1473-3099(21)00451-5","volume":"22","author":"EYF Wan","year":"2022","unstructured":"Wan EYF et al (2022) Bell\u2019s palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study. Lancet Infect Dis 22(1):64\u201372","journal-title":"Lancet Infect Dis"},{"key":"6581_CR104","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ijid.2021.08.071","volume":"111","author":"K Sato","year":"2021","unstructured":"Sato K et al (2021) Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database. Int J Infect Dis 111:310\u2013312","journal-title":"Int J Infect Dis"},{"issue":"8","key":"6581_CR105","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/jamaoto.2021.1259","volume":"147","author":"A Shemer","year":"2021","unstructured":"Shemer A et al (2021) Association of COVID-19 vaccination and facial nerve palsy: a case-control study. JAMA Otolaryngol Head Neck Surg 147(8):739\u2013743","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"8","key":"6581_CR106","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1001\/jamaoto.2021.1266","volume":"147","author":"A Tamaki","year":"2021","unstructured":"Tamaki A et al (2021) Incidence of Bell palsy in patients With COVID-19. JAMA Otolaryngology-Head & Neck Surgery 147(8):767\u2013768","journal-title":"JAMA Otolaryngology-Head & Neck Surgery"},{"key":"6581_CR107","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3389\/fneur.2020.01053","volume":"11","author":"AE Camelo-Filho","year":"2020","unstructured":"Camelo-Filho AE et al (2020) Myasthenia Gravis and COVID-19: Clinical characteristics and outcomes. Front Neurol 11:1053","journal-title":"Front Neurol"},{"issue":"6","key":"6581_CR108","first-page":"e15581","volume":"13","author":"AR Tagliaferri","year":"2021","unstructured":"Tagliaferri AR et al (2021) A case of COVID-19 vaccine causing a myasthenia gravis crisis. Cureus 13(6):e15581\u2013e15581","journal-title":"Cureus"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06581-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-022-06581-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06581-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:28:23Z","timestamp":1744158503000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-022-06581-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":108,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["6581"],"URL":"https:\/\/doi.org\/10.1007\/s10072-022-06581-z","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,9]]},"assertion":[{"value":"20 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}